|
|||||
|
|
The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end-stage renal disease and heart failure |
|
| Authors: | Donna Shu-Han Lin Fang-Ju Lin Yu-Sheng Lin Jen-Kuang Lee Yen-Hung Lin |
| Affiliation: | 1. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan;2. School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan;3. Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan College of Medicine, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan City, Taiwan;4. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;5. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Department of Laboratory Medicine, National Taiwan University College of Medicine, Taipei, Taiwan Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan |
| Abstract: | |
| Keywords: | Cardiovascular outcomes End-stage renal disease Heart failure Mineralocorticoid receptor antagonist Mortality |